Skip to main navigation Skip to search Skip to main content

Vitamin E treatment in tardive dyskinesia

  • P. N. Dannon
  • , E. Lepkifker
  • , I. Iancu
  • , R. Ziv
  • , N. Horesh
  • , M. Kotler
  • Sheba Medical Center at Tel Hashomer

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Sixteen patients with tardive dyskinesia were treated with vitamin E in an open trial of on-off-on design. Abnormal involuntary movement scale (AIMS) ratings were performed in every phase of the study. The patients exhibited a significant reduction in their mean AIMS score during vitamin E treatment. Thus, this finding may suggest a possible role for vitamin E in the treatment of tardive dyskinesia.

Original languageEnglish
Pages (from-to)217-220
Number of pages4
JournalHuman Psychopharmacology
Volume12
Issue number3
DOIs
StatePublished - May 1997
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Abnormal involuntary movement scale (AIMS)
  • Tardive dyskinesia
  • Vitamin E

Fingerprint

Dive into the research topics of 'Vitamin E treatment in tardive dyskinesia'. Together they form a unique fingerprint.

Cite this